Medios is a leading provider of high-priced complex specialty pharma products and individualized Patient-Specific Therapies in Germany

The company covers all relevant aspects of the supply chain: from pharmaceutical supply to the manufacture of patient-specific therapies including blistering. The focus is on optimal individualized patient care via specialized pharmacies

Medios announced on 25th November 2021 a purchase agreement to acquire NewCo Pharma GmbH at a €125m EV. NewCo Pharma is one of the leading regional Patient-Specific Therapy providers in Western and South-Western Germany with EUR 153m in revenues (2020) and growing double-digit

The transformative and highly-synergistic acquisition of NewCo Pharma enables Medios to significantly strengthen the higher-margin segment of Patient-Specific Therapies, making Medios the undisputed leader in Germany. The Group Patient-Specific Therapies revenues, EBITDA and annual preparation output will immediately triple while the expansion of Medios’ network of partner pharmacies and product offering represents significant cross-selling opportunities

This acquisition gives Medios a solid basis and the means to expand outside of Germany and also into new product categories

Proceeds from the offering will be used to finance the cash component for the acquisition of the NewCo Pharma Group

About Medios

Medios AG is the leading provider of Specialty Pharma solutions in Germany. As a competence partner and expert, Medios covers all relevant aspects of the supply chain in this field: from pharmaceutical supply to the manufacture of patient-specific therapies including blistering. The focus is on optimal patient care via specialized pharmacies.

Medios AG is Germany's first listed Specialty Pharma company. The shares (ISIN: DE000A1MMCC8) are listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).

Discover Medios

Falk Müller-Veerse

Investment Banking

Falk Müller-Veerse photo

Pierre Kiecolt-Wahl

Equity Capital Markets

Pierre Kiecolt-Wahl senior photo

Hervé Ronin

Investment Banking

Hervé Ronin senior photo

Sandrine Cailleteau

Investment Banking

Sandrine Cailleteau photo

Grégoire Angleys

Equity Capital Markets

Gregoire Angleys photo

Raphael Bidaut

Investment Banking

Martin Piehlmeier

Investment Banking

Martin Piehlmeier photo

Remi Negre

Investment Banking

Remi Negre photo

Théodore de Charsonville

Equity Capital Markets

Théodore De Charsonville photo

Deal Team

Should you want to know more about this transaction, you can contact one of the team members above

Privacy Preference Center

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }